| Literature DB >> 32015038 |
Gabrielle Richard1,2, C Roger MacKenzie1,2, Kevin A Henry2,3, Evgeny Vinogradov2, J Christopher Hall1, Greg Hussack4.
Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that is inherently resistant to many antibiotics and represents an increasing threat due to the emergence of drug-resistant strains. There is a pressing need to develop innovative antimicrobials against this pathogen. In this study, we identified the O-specific antigen (OSA) of P. aeruginosa serotype O6 as a novel target for therapeutic intervention. Binding of monoclonal antibodies and antigen-binding fragments therefrom to O6 OSA leads to rapid outer membrane destabilization and inhibition of cell growth. The antimicrobial effect correlated directly with antibody affinity. Antibody binding to the O antigen of a second lipopolysaccharide (LPS) type present in P. aeruginosa or to the LPS core did not affect cell viability. Atomic force microscopy showed that antibody binding to OSA resulted in early flagellum loss, formation of membrane blebs, and eventually complete outer membrane loss. We hypothesize that antibody binding to OSA disrupts a key interaction in the P. aeruginosa outer membrane. © Crown copyright 2020.Entities:
Keywords: AFM; LPS; O-specific antigen; antibacterial antibodies; atomic force microscopy; lipopolysaccharide; outer membrane disruption
Year: 2020 PMID: 32015038 PMCID: PMC7179301 DOI: 10.1128/AAC.02168-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191